Top 10 alternative sites to amzeeqhcp.com
XIMINO Extended Release Capsules
Ximino the first-and-only extended release minocycline in a capsule. Manage your patients' moderate to severe inflamed acne effectively with Ximino
ABSORICA® (isotretinoin) | Move Beyond the Breakouts
Official patient website for ABSORICA—a treatment for persistent severe (nodular) acne. Please see full Prescribing Information, including Boxed Warning, and Medication Guide.
ORENCIA® (abatacept) | Information for Healthcare Professionals
ORENCIA® (abatacept) is a prescription medication that treats adult moderate to severe RA, adult active PsA, and for patients 2 years and older with moderate to severe polyarticular JIA. Please see Indications, Important Safety Info, and Prescribing Info.
Rosacea Treatment | ZILXI® (minocycline) topical foam, 1.5%
Discover ZILXI, the first and only treatment of its kind. Learn more about what makes ZILXI different. View Patient Information. Sign up.
PROCYSBI® (cysteamine bitartrate) Delayed-release Capsules and **** Granules
PROCYSBI is the first and only cysteamine therapy with every 12-hour dosing approved for nephropathic cystinosis in patients 1 year or older.
FASENRA® (benralizumab) for Severe Eosinophilic Asthma | For HCPs
FASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
Prescription Acne Treatment | WINLEVI® (clascoterone) cream 1%
Discover WINLEVI®, the first and only topical treatment that targets acne-causing hormones in your skin. Find real patient results, cost savings information and more.
FDA-Approved Rx Cannabidiol Official EPIDIOLEX® HCP Site
Discover the first and only FDA-approved prescription cannabidiol (CBD) for Dravet syndrome or LGS in patients 2 years of age and older. See Important Safety Information.
QBREXZA® (glycopyrronium) Cloth | Excessive Underarm Sweating Option
QBREXZA is the first and only prescription cloth towelette approved to treat excessive underarm sweating (primary axillary hyperhidrosis) in people 9 years of age and older. See Important Safety Information, Full Prescribing Information, including Patient Product Information, and Instructions for Use on QBREXZA.com.
Hydroxyurea-based treatment for pediatric patients with sickle cell anemia – Siklos® (hydroxyurea)
Siklos® is the first and only FDA-approved prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusion in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. See Important Safety Information and Boxed Warning about myelosuppression and malignancies.
Author: Super User